Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 101, Issue 4, 2008, Pages 446-451

  Smit, Jaap Jan J ^a   Ottervanger, Jan Paul ^a   Slingerland, Robbert J ^a   Kolkman, J J Evelien ^a   Suryapranata, Harry ^a   Hoorntje, Jan C A ^a   Dambrink, Jan Henk E ^a   Gosselink, A T Marcel ^a   de Boer, Menko Jan ^a   Zijlstra, Felix ^b   van 't Hof, Arnoud W J ^a  

^a Isala Klinieken ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LACTATE DEHYDROGENASE;

AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE MARKER; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE;

AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOTENSION; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RECURRENCE; STROKE VOLUME;

EID: 38849124196     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.088     Document Type: Article

References (30)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Gonzalez M.A., and Selwyn A.P. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 115 (2003) 99S-106S
3. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
4. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 (2005) 1609-1616
5. Sabatine M.S., Morrow D.A., Cannon C.P., Murphy S.A., Demopoulos L.A., DiBattiste P.M., McCabe C.H., Braunwald E., and Gibson C.M. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 40 (2002) 1761-1768
6. Brunetti N.D., Troccoli R., Correale M., Pellegrino P.L., and Di Biase M. C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol 109 (2006) 248-256
7. Sanchis J., Bodi V., Llacer A., Nunez J., Facila L., Ruiz V., Blasco M., Sanjuan R., and Chorro F.J. Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction. Am J Cardiol 94 (2004) 766-769
8. Voulgari F., Cummins P., Gardecki T.I., Beeching N.J., Stone P.C., and Stuart J. Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. Br Heart J 48 (1982) 352-356
9. Zairis M.N., Manousakis S.J., Stefanidis A.S., Papadaki O.A., Andrikopoulos G.K., Olympios C.D., Hadjissavas J.J., Argyrakis S.K., and Foussas S.G. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 144 (2002) 782-789
10. Muhlestein J.B., Horne B.D., Carlquist J.F., Madsen T.E., Bair T.L., Pearson R.R., and Anderson J.L. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102 (2000) 1917-1923
11. Ferreiros E.R., Boissonnet C.P., Pizarro R., Merletti P.F., Corrado G., Cagide A., and Bazzino O.O. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 100 (1999) 1958-1963
12. Friedman G.D., Klatsky A.L., and Siegelaub A.B. Leukocyte count as a predictor of myocardial infarction. N Engl J Med 290 (1974) 1275-1278
13. Haines A.P., Howarth D., North W.R., Goldenberg E., Stirling Y., Meade T.W., Raftery E.B., and Millar Craig M.W. Haemostatic variables and the outcome of myocardial infarction. Thromb Haemost 50 (1983) 800-803
14. Furman M.I., Becker R.C., Yarzebski J., Savegeau J., Gore J.M., and Goldberg R.J. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 78 (1996) 945-948
15. Cannon C.P., McCabe C.H., Wilcox R.G., Bentley J.H., Braunwald E., and OPUS-TIMI 16 Investigators. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 87 (2001) 636-639
16. Barron H.V., Harr S.D., Radford M.J., Wang Y., and Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients ≥ 65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 38 (2001) 1654-1661
17. van 't Hof A.W.J., Ernst N.M., de Boer M.J., de Winter R., Boersma E., Bunt T., Petronio S., Gosselink A.T.M., Jap W., Hollak F., Hoorntje J.C.A., Suryapranata H., Dambrink J.H.E., Zijlstra F., and On-TIME study group. Facilitation of primary coronary angioplasty by early start of glycoprotein IIb/IIIa inhibitor: results of the ongoing tirofiban in myocardial evaluation (On-TIME) trial. Eur Heart J 25 (2004) 837-846
18. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., and Ludbrook P. Thrombolysis In Myocardial Infarction (TIMI) trial, phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76 (1987) 142-154
19. van 't Hof A.W.J., Liem A., Suryapranata H., Hoorntje J.C.A., de Boer M.J., Zijlstra F., and Zwolle myocardial infarction study group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97 (1998) 2302-2306
20. van 't Hof A.W.J., de Vries S.T., Dambrink J.H.E., Miedema K., Suryapranata H., Hoorntje J.C.A., Gosselink A.T.M., Zijlstra F., and de Boer M.J. A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. Eur Heart J 24 (2003) 1401-1405
21. Kinjo K., Sato H., Ohnishi Y., Hishida E., Nakatani D., Mizuno H., Imai K., Nanto S., Naka M., Matsumura Y., Takeda H., Hori M., and Osaka Acute Coronary Insufficiency Study (OACIS) Group. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 91 (2003) 931-935
22. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease. J Am Coll Cardiol 44 (2004) 1945-1956
23. Smit J.J.J., Ottervanger J.P., Slingerland R.J., Suryapranata H., Hoorntje J.C.A., Dambrink J.H.E., Gosselink A.T.M., de Boer M.J., van 't Hof A.W.J., and On-TIME study group. Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count. J Lab Clin Med 147 (2006) 321-326
24. Pietila K.O., Harmoinen A.P., Jokiniitty J., and Pasternack A.I. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 17 (1996) 1345-1349
25. Kushner I., Broder M.L., and Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 61 (1978) 235-242
26. Lincoff A.M., Kereiakes D.J., Mascelli M.A., Deckelbaum L.I., Barnathan E.S., Patel K.K., Frederick B., Nakada M.T., and Topol E.J. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 104 (2001) 163-167
27. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C., and Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98 (1998) 839-844
28. Prasad A., Stone G.W., Stuckey T.D., Costantini C.O., Mehran R., Garcia E., Tcheng J.E., Cox D.A., Grines C.L., Lansky A.J., and Gersh B.J. Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. Am J Cardiol 99 (2007) 1067-1071
29. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., and Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion and clinical outcomes in the setting of acute myocardial infarction. Circulation 102 (2000) 2329-2334
30. Abdelmouttaleb I., Danchin N., Ilardo C., Aimone-Gastin I., Angioï M., Lozniewski A., Loubinoux J., Le Faou A., and Guéant J.L. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 138 (1999) 999-1000